Financial Daily from THE HINDU group of publications
Thursday, May 25, 2006


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements


Four Ranbaxy HIV/AIDS drugs in WHO pre-qualification list

Our Bureau

New Delhi , May 24

Ranbaxy Laboratories Ltd has said that the World Health Organisation (WHO) has included four of its additional anti-retroviral (ARV) products in its pre-qualification list.

The products approved by WHO are Efavirenz 600 mg tablets, Efavirenz 200 mg capsules, Stavudine 30 mg capsules and Stavudine 40 mg capsules, the company said in a statement.

"This is a significant development. We strongly feel that generic ARVs are essential in the struggle against HIV/AIDS and are committed to providing high quality, cost effective generics," the Ranbaxy CEO and Managing Director, Mr Malvinder Mohan Singh, said.

With these inclusions, Ranbaxy now has a total of 12 ARVs on the WHO pre-qualification list.

It also has three approvals from USFDA for ARVs, making it eligible for supplying to the US funded PEPFAR programme.

"Efavirenz is rapidly becoming a preferred drug in the HIV treatment programme in developing countries.

"The other newly listed drug, Stavudine, is also being widely used as a first line of therapy against AIDS. Both products increase customer choice enabling patients to access therapy easily, at affordable prices," Mr Singh said.

Ranbaxy has been providing ARVs at affordable prices to countries and patients afflicted by HIV/AIDS since 2001.

More Stories on : Announcements | Pharmaceuticals | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Panel concern over ONGC's safety mechanism


Four Ranbaxy HIV/AIDS drugs in WHO pre-qualification list
L&T bags Uttaranchal power project
Unitech bags major Noida land project
RAK Ceramics to start production soon
Sirpur Paper AGM postponed
UB Group may not hike offer price for Champagne Taittinger
Marg Const plans FCCBs for port project
Insurance for auditors
Dishman to buy Swiss co Solutia's unit
Spentex takes management control in Indo Rama Textiles
Harting to open Indian operations in Chennai
Ranbaxy to market Ethypharm drug
Opto Circuits arm in pact
OVL gets Cuban Govt nod for 30 pc interest in 6 blocks
GAIL-led venture to implement Assam gas project
Unitech not planning equity dilution
Reliance eyes cane processing
A different process
NTC targets cash profits; confident of wiping out losses
Poly Medicure to leverage US acquisition for expansion
Uncertainty prevails over ONGC chief's tenure
New V-P for Heritage Foods



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line